Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Supply Side East In Brief

This article was originally published in The Tan Sheet

Executive Summary

Roche: Firm promotes three delivery forms of lycopene at Supply Side East in Secaucus, N.J. May 6-8. Five-percent beadlet, 10% water dispersible beadlet and 10% fluid suspension based in corn oil launched in April, Roche says. Ingredient can be used in juices, nutritional bars, meal replacement drinks, soups, yogurts and other foods, firm adds. According to company representatives, Hoffmann-La Roche is scheduled to make a decision regarding the future of its vitamin division in early June. Chairman & CEO Franz Humer noted the company was considering selling the division at a Feb. 28 financial meeting in New York (1"The Tan Sheet" March 4, 2002, p. 3). Roche plans to complete the process by year-end, reps note...

You may also be interested in...



Roche Vitamins Divestiture Will Not Occur Piecemeal, Chairman Says

Hoffman-La Roche's Vitamins & Fine Chemicals division could be sold to a raw material supplier without a substantial presence in vitamins or to a large food manufacturer

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094045

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel